Trials / Not Yet Recruiting
Not Yet RecruitingNCT06704880
CONSTRAINT-INDUCED MOVEMENT THERAPY VERSUS CROSS EDUCATION IN CHILDREN WITH CEREBRAL PALSY
Lower Limb Constraint-induced Movement Training Versus Strength Training of the Non-hemiplegic Lower Limb on Motor Performance in Children With Hemiplegic Cerebral Palsy: A Randomized Control Trial.
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Imam Abdulrahman Bin Faisal University · Academic / Other
- Sex
- All
- Age
- 5 Years – 15 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial aims to Compare the effectiveness of lower limb CIMT and the Strength Training of the Non-Hemiplegic lower limb on motor performance in hemiplegic children with CP. Participants will: diagnosed with hemiplegic cerebral palsy treated with CIMT or Strength training (cross-education) for a non-hemiplegic limb for 8 weeks. 3 sessions per week. Measurements will be taken at baseline and then at the end of the 8 weeks.
Detailed description
Method: 32 children with hemiplegic CP will be equally and randomly allocated to two groups (group A and B). group A will receive lower limb CIMT for the non- hemiplegic limb using whole leg orthosis and Group B will receive strengthen training for the non-hemiplegic lower limb. Both groups will receive routine physical therapy for the hemiplegic lower limb. Both groups will receive 60 minutes training session for 3 sessions per week for 8 consecutive weeks. Assessment will be at baseline then at the end of trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | rehabilitation | children in the CIMT group will RECIEVE lower limb CIMT for the non-hemiplegic limb using whole leg orthosis. Children in cross-education group will receive strengthening training for the non-hemiplegic lower limb |
Timeline
- Start date
- 2024-11-30
- Primary completion
- 2025-02-28
- Completion
- 2025-04-29
- First posted
- 2024-11-26
- Last updated
- 2024-11-26
Locations
1 site across 1 country: Saudi Arabia
Source: ClinicalTrials.gov record NCT06704880. Inclusion in this directory is not an endorsement.